Ergometrine for postpartum hemorrhage and associated myocardial ischemia: Two case reports and a review of the literature
- PMID: 31893076
- PMCID: PMC6935658
- DOI: 10.1002/ccr3.2516
Ergometrine for postpartum hemorrhage and associated myocardial ischemia: Two case reports and a review of the literature
Abstract
Ergometrine is recommended for use in the medical treatment of postpartum hemorrhage. Ergometrine can occasionally precipitate myocardial ischemia in the setting of significant anemia in women without preexisting cardiac risk factors, and it is important to recognize and treat myocardial ischemia in affected patients to prevent severe complications.
Keywords: acute coronary syndrome; anemia; ergometrine; myocardial ischemia; postpartum hemorrhage.
© 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare that they have no competing interests.
References
-
- Mavrides E, Allard S, Chandraharan E, et al. Prevention and management of postpartum haemorrhage. BJOG. 2016;124:e106‐e149. - PubMed
-
- Santoro F, Spennati G, Ieva R, et al. Late onset of coronary vasospasm after administration of methyl‐ergometrine for gynaecologic bleeding. Int J Cardiol. 2012;161:e29‐e30. - PubMed
-
- Lin YH, Seow K‐M, Hwang J‐L, Chen H‐H. Myocardial infarction and mortality caused by methylergonovine. Acta Obstet Gynecol Scand. 2005;84:1022. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
